Get startedLog in
    Picture of Supernus Pharmaceuticals logo

    SUPN — Supernus Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareBalancedMid CapHigh Flyer
    All News

    Brief: Supernus Announces FDA Approval Of Qelbree For The Treatment Of ADHD In Adults

    Picture of Supernus Pharmaceuticals logoSupernus Pharmaceuticals
    02/05/2022 14:16
    May 2 (Reuters) - Supernus Pharmaceuticals Inc  SUPN.O :
    * SUPERNUS ANNOUNCES FDA APPROVAL OF QELBREE® FOR THE TREATMENT OF ADHD IN
ADULTS

Source text for Eikon:  ID:nPn6zlWQJa 
Further company coverage:  SUPN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Supernus Pharmaceuticals

    See all news